1. Home
  2. PHIO vs ELOG Comparison

PHIO vs ELOG Comparison

Compare PHIO & ELOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Phio Pharmaceuticals Corp.

PHIO

Phio Pharmaceuticals Corp.

HOLD

Current Price

$1.12

Market Cap

11.2M

Sector

Health Care

ML Signal

HOLD

Logo Eastern International Ltd. Ordinary Shares

ELOG

Eastern International Ltd. Ordinary Shares

HOLD

Current Price

$0.70

Market Cap

9.0M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
PHIO
ELOG
Founded
2003
2006
Country
United States
China
Employees
N/A
138
Industry
Biotechnology: Pharmaceutical Preparations
Integrated Freight & Logistics
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
11.2M
9.0M
IPO Year
2011
2024

Fundamental Metrics

Financial Performance
Metric
PHIO
ELOG
Price
$1.12
$0.70
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$14.00
N/A
AVG Volume (30 Days)
146.6K
2.8K
Earning Date
05-14-2026
07-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$6.84
Revenue Growth
N/A
N/A
52 Week Low
$0.81
$0.70
52 Week High
$4.19
$3.07

Technical Indicators

Market Signals
Indicator
PHIO
ELOG
Relative Strength Index (RSI) 53.92 39.71
Support Level $0.99 N/A
Resistance Level $1.14 $0.98
Average True Range (ATR) 0.06 0.07
MACD 0.00 -0.01
Stochastic Oscillator 50.00 0.00

Price Performance

Historical Comparison
PHIO
ELOG

About PHIO Phio Pharmaceuticals Corp.

Phio Pharmaceuticals Corp is a clinical-stage biopharmaceutical company whose proprietary INTASYL small-interfering RNA gene silencing technology is designed to make immune cells more effective in killing tumor cells. Its pipeline programs are PH-762 and PH-894. The group is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems. It is committed to discovering and developing cancer treatments for patients by creating new pathways toward a cancer-free future. The Company operates with a single operating segment, the Clinical segment, and all assets are located in the United States.

About ELOG Eastern International Ltd. Ordinary Shares

Eastern International Ltd is a holding company. The company operates through its subsidiary engaged in domestic and cross-border professional logistic services including project logistics and general logistics for company clients. Its project logistic services include Construction project logistics and special cargo logistics for large or precision equipment and General logistic services refer to the transportation, warehousing, loading and unloading, and distribution of ordinary products.

Share on Social Networks: